News

Media

27. November, 2020

Massiv interesse for børsnotering

Det nystiftede bioselskab Cessatech med en tidligere Lundbeck-direktør i spidsen og prominente folk i...

Read more

Releases

27. November, 2020

Cessatech’s IPO of units significantly oversubscribed

Subscribed to DKK 107 million, corresponding to a subscription ratio of approx. 680 percent....

Read more

Media

24. November, 2020

CESSATECH VILL BEDÖVA BARN VIA NÄSAN

STOCKHOLM (Nyhetsbyrån Direkt) Det danska forskningsbolaget Cessatech, som utvecklar behandlingar för barn, tänker ge...

Read more

Media

10. November, 2020

Cessatech mot börsen med nässpray mot smärta

Danska Cessatech har utvecklat en nässpray för smärtlindring speciellt anpassad för barn. Den ska...

Read more

Releases

6. November, 2020

Approval for IPO listing

Cessatech A/S today announces that Spotlight Stock Market’s listing committee has approved Cessatech’s application...

Read more

Facts

31. August, 2020

DR.dk focus

Kan give voldsomme bivirkninger, når børn og ældre får medicin, der ikke er godkendt til dem...

Read more

Releases

18. August, 2020

Strong profiles to the Board

The Board has a wide experience from the entire value chain, which is a strong asset for Cessatech and its future aspirations

Read more

Media

26. May, 2020

Copenhagen Science

Novel painkiller is remarkably close to market, and the team is now expanding its business development activities

Read more

Facts

1. May, 2020

High off-label use

Studies are still needed to determine the safety and efficacy of drugs that lack FDA labeling for this vulnerable patient population. Drugs were administered off-label...

Read more

Facts

1. May, 2020

Small adults?

Children differ pharmacokinetically from adults, and medication for adults cannot simply be administered in smaller doses

Read more

Media

14. December, 2019

TV2 Nyhederne

En nyudviklet næsespray, er dagens store nyhed i TV2 Nyhederne - udviklet på Rigshospitalet af ledende eksperter

Read more

Stay up to date!

Subscribe and get notified on Cessatech's latest news.